BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33355042)

  • 1. Comprehensive Bioinformatics Analysis of Key Methyltransferases and Demethylases for Histone Lysines in Hepatocellular Carcinoma.
    Zheng Y; Tang L; Chen G; Liu Z
    Technol Cancer Res Treat; 2020; 19():1533033820983284. PubMed ID: 33355042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular landscape of histone lysine methyltransferases and demethylases in non-small cell lung cancer.
    Li J; Tao X; Shen J; Liu L; Zhao Q; Ma Y; Tao Z; Zhang Y; Ding B; Xiao Z
    Int J Med Sci; 2019; 16(7):922-930. PubMed ID: 31341405
    [No Abstract]   [Full Text] [Related]  

  • 3. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets.
    Bayo J; Fiore EJ; Dominguez LM; Real A; Malvicini M; Rizzo M; Atorrasagasti C; García MG; Argemi J; Martinez ED; Mazzolini GD
    J Hepatol; 2019 Jul; 71(1):78-90. PubMed ID: 30880225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Advances in histone methyltransferases and histone demethylases].
    Wang X; Zhu WG
    Ai Zheng; 2008 Oct; 27(10):1018-25. PubMed ID: 18851779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma.
    Qu LH; Fang Q; Yin T; Yi HM; Mei GB; Hong ZZ; Qiu XB; Zhou R; Dong HF
    Cancer Immunol Immunother; 2022 Oct; 71(10):2449-2467. PubMed ID: 35254477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Writing, erasing and reading histone lysine methylations.
    Hyun K; Jeon J; Park K; Kim J
    Exp Mol Med; 2017 Apr; 49(4):e324. PubMed ID: 28450737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crosstalk between epigenetics and metabolism-Yin and Yang of histone demethylases and methyltransferases in cancer.
    Filipp FV
    Brief Funct Genomics; 2017 Nov; 16(6):320-325. PubMed ID: 28369194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of histone methylation in skin cancers: Histone methylation-modifying enzymes as a new class of targets for skin cancer treatment.
    Sutopo NC; Kim JH; Cho JY
    Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188865. PubMed ID: 36841366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
    Morera L; Lübbert M; Jung M
    Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of SET domain bifurcated histone lysine methyltransferase 1 and its clinical prognostic significance in hepatocellular carcinoma.
    Wang C; Xia Z; Li Z; Ye F; Ji S; Lu C; Zhang H
    J Clin Lab Anal; 2022 Jan; 36(1):e24090. PubMed ID: 34843122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting Histone Methylation in Cancer.
    McCabe MT; Mohammad HP; Barbash O; Kruger RG
    Cancer J; 2017; 23(5):292-301. PubMed ID: 28926430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controllers of histone methylation-modifying enzymes in gastrointestinal cancers.
    Li L; Song Q; Zhou J; Ji Q
    Biomed Pharmacother; 2024 May; 174():116488. PubMed ID: 38520871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current perspectives on histone demethylases.
    Tian X; Fang J
    Acta Biochim Biophys Sin (Shanghai); 2007 Feb; 39(2):81-8. PubMed ID: 17277881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of histone lysine methylation: structures of methyl writers and erasers.
    Upadhyay AK; Cheng X
    Prog Drug Res; 2011; 67():107-24. PubMed ID: 21141727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR/Cas9-mediated knockout of NSD1 suppresses the hepatocellular carcinoma development via the NSD1/H3/Wnt10b signaling pathway.
    Zhang S; Zhang F; Chen Q; Wan C; Xiong J; Xu J
    J Exp Clin Cancer Res; 2019 Nov; 38(1):467. PubMed ID: 31727171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
    Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO
    Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting protein lysine methylation and demethylation in cancers.
    He Y; Korboukh I; Jin J; Huang J
    Acta Biochim Biophys Sin (Shanghai); 2012 Jan; 44(1):70-9. PubMed ID: 22194015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone methyl transferases and demethylases; can they link metabolism and transcription?
    Teperino R; Schoonjans K; Auwerx J
    Cell Metab; 2010 Oct; 12(4):321-327. PubMed ID: 20889125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The future therapeutic potential of histone demethylases: A critical analysis.
    Natoli G; Testa G; De Santa F
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):607-15. PubMed ID: 19736620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of histone modifications and variants in regulating gene expression in breast cancer.
    Dalvai M; Bystricky K
    J Mammary Gland Biol Neoplasia; 2010 Mar; 15(1):19-33. PubMed ID: 20131086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.